These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6235076)
21. Cardiohaemodynamic effects of long-term intravenous administration of N-(2-hydroxyethyl)nicotinamide nitrate (SG-75), a potent coronary vasodilator: comparison with glyceryl trinitrate. Sakai K; Shiraki Y; Yamazaki T; Akima M; Nabata H; Ohba Y Clin Exp Pharmacol Physiol; 1981; 8(6):557-65. PubMed ID: 6460572 [TBL] [Abstract][Full Text] [Related]
22. Double-blind comparison of the acute effects of two relevant doses of oral nicorandil on central hemodynamics, left ventricular function, and myocardial contractility. Baumbach A; Braun U; Döring G; Haase KK; Voelker W; Karsch KR Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():213-20. PubMed ID: 7647025 [TBL] [Abstract][Full Text] [Related]
23. Improved recovery of myocardial segment function following a short coronary occlusion in dogs by nicorandil, a potential new antianginal agent, and nifedipine. Lamping KA; Gross GJ J Cardiovasc Pharmacol; 1985; 7(1):158-66. PubMed ID: 2580137 [TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of nicorandil on cardiovascular hemodynamics and left ventricular function. Kambara H; Nakamura Y; Tamaki S; Kawai C J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S104-8. PubMed ID: 2447416 [TBL] [Abstract][Full Text] [Related]
25. Pharmacology and therapeutic effects of nicorandil. Kinoshita M; Sakai K Cardiovasc Drugs Ther; 1990 Aug; 4(4):1075-88. PubMed ID: 2150592 [TBL] [Abstract][Full Text] [Related]
26. Effects of nicorandil on left ventricular hemodynamics and volume at rest and during exercise-induced angina pectoris. Silke B; Verma SP; Ali MS; Goldhammer E; Taylor SH Am J Cardiol; 1989 Jun; 63(21):49J-55J. PubMed ID: 2525326 [TBL] [Abstract][Full Text] [Related]
27. Coronary microvascular response to intracoronary administration of nicorandil. Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132 [TBL] [Abstract][Full Text] [Related]
28. Beneficial effect of concomitant administration of isoflurane and nicorandil. Piriou V; Ross S; Pigott D; Evans R; Foex P Br J Anaesth; 1997 Jul; 79(1):68-77. PubMed ID: 9301392 [TBL] [Abstract][Full Text] [Related]
29. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium. Gross GJ; Pieper GM; Warltier DC J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S76-84. PubMed ID: 2447429 [TBL] [Abstract][Full Text] [Related]
30. Nicorandil: animal pharmacology. Sakai K Am J Cardiol; 1989 Jun; 63(21):2J-10J. PubMed ID: 2525321 [TBL] [Abstract][Full Text] [Related]
32. Cardiovascular effects of a new coronary vasodilator N-(2-hydroxyethyl)nicotinamide nitrate (SG-75): comparison with nitroglycerin and diltiazem. Sakai K; Shiraki Y; Nabata H J Cardiovasc Pharmacol; 1981; 3(1):139-50. PubMed ID: 6160343 [TBL] [Abstract][Full Text] [Related]
33. [Effect of nicorandil on coronary circulation in ischemic region]. Chen SL; Zhu MZ; Feng XB; Li LS; Zang YM Zhongguo Yao Li Xue Bao; 1990 May; 11(3):249-53. PubMed ID: 2150905 [TBL] [Abstract][Full Text] [Related]
34. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Frampton J; Buckley MM; Fitton A Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076 [TBL] [Abstract][Full Text] [Related]
35. Effects of nicorandil and nifedipine on protection of ischemic myocardium. Lamping KA; Christensen CW; Pelc LR; Warltier DC; Gross GJ J Cardiovasc Pharmacol; 1984; 6(3):536-42. PubMed ID: 6202983 [TBL] [Abstract][Full Text] [Related]
36. Comparative effects of a new nicotinamide nitrate derivative, nicorandil (SG 75), with nifedipine and nitroglycerin on true collateral blood flow following an acute coronary occlusion in dogs. Lamping KA; Gross GJ J Cardiovasc Pharmacol; 1984; 6(4):601-8. PubMed ID: 6206313 [TBL] [Abstract][Full Text] [Related]
37. Enhanced subendocardial perfusion distal to a flow-limiting coronary artery stenosis in dogs: comparative effects of nicorandil, a potential new antianginal agent, and nitroglycerin. Gross GJ; Warltier DC; Hardman HF; Lamping KA J Cardiovasc Pharmacol; 1985; 7(5):977-82. PubMed ID: 2413311 [TBL] [Abstract][Full Text] [Related]
38. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. Krumenacker M; Roland E J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184 [TBL] [Abstract][Full Text] [Related]
39. Nicorandil and cardiovascular performance in patients with coronary artery disease. Suryapranata H; MacLeod D J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S45-51. PubMed ID: 1282175 [TBL] [Abstract][Full Text] [Related]
40. Cardiovascular and pharmacokinetic interactions between nicorandil and adjunctive propranolol, atenolol or diltiazem in conscious dogs. Humphrey SJ Methods Find Exp Clin Pharmacol; 1998 Nov; 20(9):779-91. PubMed ID: 10022032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]